Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults.
Identifieur interne : 000031 ( Main/Exploration ); précédent : 000030; suivant : 000032Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults.
Auteurs : Esther C. De Haas [Pays-Bas] ; Hendrika J. Luijendijk [Pays-Bas]Source :
- European journal of internal medicine [ 1879-0828 ] ; 2019.
Descripteurs français
- KwdFr :
- Adulte, Antiviraux (pharmacocinétique), Antiviraux (pharmacologie), Canada, Essais cliniques comme sujet, Grippe humaine (traitement médicamenteux), Humains, Japon, Oxazines (pharmacocinétique), Oxazines (pharmacologie), Pyridines (pharmacocinétique), Pyridines (pharmacologie), Résultat thérapeutique, Sélection de patients, Thiépines (pharmacocinétique), Thiépines (pharmacologie), Triazines (pharmacocinétique), Triazines (pharmacologie), États-Unis d'Amérique.
- MESH :
- pharmacocinétique : Antiviraux, Oxazines, Pyridines, Thiépines, Triazines.
- pharmacologie : Antiviraux, Oxazines, Pyridines, Thiépines, Triazines.
- traitement médicamenteux : Grippe humaine.
- Adulte, Canada, Essais cliniques comme sujet, Humains, Japon, Résultat thérapeutique, Sélection de patients, États-Unis d'Amérique.
- Wicri :
- geographic : Canada, Japon, États-Unis.
English descriptors
- KwdEn :
- Adult, Antiviral Agents (pharmacokinetics), Antiviral Agents (pharmacology), Bias, Canada, Clinical Trials as Topic, Humans, Influenza, Human (drug therapy), Japan, Oxazines (pharmacokinetics), Oxazines (pharmacology), Patient Selection, Pyridines (pharmacokinetics), Pyridines (pharmacology), Thiepins (pharmacokinetics), Thiepins (pharmacology), Treatment Outcome, Triazines (pharmacokinetics), Triazines (pharmacology), United States.
- MESH :
- chemical , pharmacokinetics : Antiviral Agents, Oxazines, Pyridines, Thiepins, Triazines.
- chemical , pharmacology : Antiviral Agents, Oxazines, Pyridines, Thiepins, Triazines.
- geographic : Canada, Japan, United States.
- drug therapy : Influenza, Human.
- Adult, Bias, Clinical Trials as Topic, Humans, Patient Selection, Treatment Outcome.
DOI: 10.1016/j.ejim.2018.12.002
PubMed: 30857671
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults.</title><author><name sortKey="De Haas, Esther C" sort="De Haas, Esther C" uniqKey="De Haas E" first="Esther C" last="De Haas">Esther C. De Haas</name><affiliation wicri:level="1"><nlm:affiliation>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen, The Netherlands. Electronic address: e.de.haas@umcg.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen</wicri:regionArea><wicri:noRegion>9700 AD Groningen</wicri:noRegion></affiliation></author><author><name sortKey="Luijendijk, Hendrika J" sort="Luijendijk, Hendrika J" uniqKey="Luijendijk H" first="Hendrika J" last="Luijendijk">Hendrika J. Luijendijk</name><affiliation wicri:level="1"><nlm:affiliation>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen</wicri:regionArea><wicri:noRegion>9700 AD Groningen</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:30857671</idno><idno type="pmid">30857671</idno><idno type="doi">10.1016/j.ejim.2018.12.002</idno><idno type="wicri:Area/Main/Corpus">000019</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000019</idno><idno type="wicri:Area/Main/Curation">000019</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000019</idno><idno type="wicri:Area/Main/Exploration">000019</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults.</title><author><name sortKey="De Haas, Esther C" sort="De Haas, Esther C" uniqKey="De Haas E" first="Esther C" last="De Haas">Esther C. De Haas</name><affiliation wicri:level="1"><nlm:affiliation>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen, The Netherlands. Electronic address: e.de.haas@umcg.nl.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen</wicri:regionArea><wicri:noRegion>9700 AD Groningen</wicri:noRegion></affiliation></author><author><name sortKey="Luijendijk, Hendrika J" sort="Luijendijk, Hendrika J" uniqKey="Luijendijk H" first="Hendrika J" last="Luijendijk">Hendrika J. Luijendijk</name><affiliation wicri:level="1"><nlm:affiliation>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen, The Netherlands.</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen</wicri:regionArea><wicri:noRegion>9700 AD Groningen</wicri:noRegion></affiliation></author></analytic><series><title level="j">European journal of internal medicine</title><idno type="eISSN">1879-0828</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antiviral Agents (pharmacokinetics)</term><term>Antiviral Agents (pharmacology)</term><term>Bias</term><term>Canada</term><term>Clinical Trials as Topic</term><term>Humans</term><term>Influenza, Human (drug therapy)</term><term>Japan</term><term>Oxazines (pharmacokinetics)</term><term>Oxazines (pharmacology)</term><term>Patient Selection</term><term>Pyridines (pharmacokinetics)</term><term>Pyridines (pharmacology)</term><term>Thiepins (pharmacokinetics)</term><term>Thiepins (pharmacology)</term><term>Treatment Outcome</term><term>Triazines (pharmacokinetics)</term><term>Triazines (pharmacology)</term><term>United States</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Antiviraux (pharmacocinétique)</term><term>Antiviraux (pharmacologie)</term><term>Canada</term><term>Essais cliniques comme sujet</term><term>Grippe humaine (traitement médicamenteux)</term><term>Humains</term><term>Japon</term><term>Oxazines (pharmacocinétique)</term><term>Oxazines (pharmacologie)</term><term>Pyridines (pharmacocinétique)</term><term>Pyridines (pharmacologie)</term><term>Résultat thérapeutique</term><term>Sélection de patients</term><term>Thiépines (pharmacocinétique)</term><term>Thiépines (pharmacologie)</term><term>Triazines (pharmacocinétique)</term><term>Triazines (pharmacologie)</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Antiviral Agents</term><term>Oxazines</term><term>Pyridines</term><term>Thiepins</term><term>Triazines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term><term>Oxazines</term><term>Pyridines</term><term>Thiepins</term><term>Triazines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Canada</term><term>Japan</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Antiviraux</term><term>Oxazines</term><term>Pyridines</term><term>Thiépines</term><term>Triazines</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term><term>Oxazines</term><term>Pyridines</term><term>Thiépines</term><term>Triazines</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Bias</term><term>Clinical Trials as Topic</term><term>Humans</term><term>Patient Selection</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Canada</term><term>Essais cliniques comme sujet</term><term>Humains</term><term>Japon</term><term>Résultat thérapeutique</term><term>Sélection de patients</term><term>États-Unis d'Amérique</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term><term>Japon</term><term>États-Unis</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30857671</PMID><DateCompleted><Year>2019</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0828</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><PubDate><Year>2019</Year><Month>04</Month></PubDate></JournalIssue><Title>European journal of internal medicine</Title><ISOAbbreviation>Eur. J. Intern. Med.</ISOAbbreviation></Journal><ArticleTitle>Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults.</ArticleTitle><Pagination><MedlinePgn>e8-e9</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0953-6205(18)30467-9</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejim.2018.12.002</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Haas</LastName><ForeName>Esther C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen, The Netherlands. Electronic address: e.de.haas@umcg.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luijendijk</LastName><ForeName>Hendrika J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>University Medical Centre Groningen, University of Groningen | Department of General Practice and Elderly Care Medicine, PO Box 196, 9700 AD Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>03</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Eur J Intern Med</MedlineTA><NlmUniqueID>9003220</NlmUniqueID><ISSNLinking>0953-6205</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010078">Oxazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011725">Pyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013846">Thiepins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014227">Triazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>4G86Y4JT3F</RegistryNumber><NameOfSubstance UI="C000628402">baloxavir</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010078" MajorTopicYN="N">Oxazines</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013846" MajorTopicYN="N">Thiepins</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014227" MajorTopicYN="N">Triazines</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Baloxavir</Keyword><Keyword MajorTopicYN="Y">Clinical trial</Keyword><Keyword MajorTopicYN="Y">Enrichment</Keyword><Keyword MajorTopicYN="Y">Influenza</Keyword><Keyword MajorTopicYN="Y">Pooling</Keyword><Keyword MajorTopicYN="Y">Validity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30857671</ArticleId><ArticleId IdType="pii">S0953-6205(18)30467-9</ArticleId><ArticleId IdType="doi">10.1016/j.ejim.2018.12.002</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Pays-Bas</li></country></list><tree><country name="Pays-Bas"><noRegion><name sortKey="De Haas, Esther C" sort="De Haas, Esther C" uniqKey="De Haas E" first="Esther C" last="De Haas">Esther C. De Haas</name></noRegion><name sortKey="Luijendijk, Hendrika J" sort="Luijendijk, Hendrika J" uniqKey="Luijendijk H" first="Hendrika J" last="Luijendijk">Hendrika J. Luijendijk</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000031 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000031 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30857671
|texte= Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30857671" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |